The US peptide therapeutics market is anticipated to project a CAGR of 5.0%, during the forecast period. The major factor that contributes to the country’s market growth is continuously increasing healthcare spending. According to the Peptide Therapeutics Foundation, the number of new peptides entering the clinic has been doubled in the past decade. Additionally, the four of the US-approved peptides have also achieved global sales over $1 billion. There are more than 54 therapeutic peptides that have been approved across the globe out of which the US has a considerable share of 26 drugs. Such data showcase the substantial growth of the US in the global peptide market.

Request a free sample of our report on US Peptide Therapeutics Market: https://www.omrglobal.com/request-sample/us-peptide-therapeutics-market

The US peptide therapeutics market is segmented on the basis of route of administration and application. Based on the route of administration, the market is bifurcated into parenteral administration and oral administration. On the basis of application, the market is segmented into cancer, metabolic disorder (diabetes & obesity), gastrointestinal disorders, central nervous system disorders, respiratory disorders, and others including chronic kidney diseases, osteoporosis, and autoimmune disorder. Among these applications, the metabolic disorder dominates the market in the US. The increasing prevalence of diabetes globally created demand for insulin and hence drives the market growth.

A full report of US Peptide Therapeutics Market Is available at https://www.omrglobal.com/industry-reports/us-peptide-therapeutics-market

US Peptide Therapeutics Market Segmentation

By Route of Administration

Oral

Parenteral

By Application

Cancer

Metabolic Disorder

Gastrointestinal Disorders

Central Nervous System Disorders

Respiratory Disorders

Others (Kidney Disorder and Autoimmune Disorder)

Company Profiles

Amgen, Inc.

Overview

Amgen Inc. in Peptide Therapeutics Landscape

Recent Developments

AstraZeneca PLC

Bristol Myers Squibb Co.

Eli Lilly and Co.

F. Hoffmann-La Roche Ltd.

GlaxoSmithKline PLC

Merck & Co., Inc.

Novartis International AG

Novo Nordisk A/S

Pfizer Inc.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/us-peptide-therapeutics-market

About Us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404